Inga Rødahl from the Center for Infectious Medicine (CIM) at the Department of Medicine, Huddinge (MedH) is defending her ...

A team of researchers from the Hospital del Mar Research Institute, the Universitat Autònoma de Barcelona and the Pompeu Fabra University has developed a new tool that allows modifying these NK cells ...

Certain subsets of immune NK cells were altered in the blood of people with ALS, and could serve as therapeutic targets, a ...

The switch from autologous to off-the-shelf products is a key step in taking the modality into the mainstream, driving a surge in allogeneic cell therapy R&D activity. NK (natural killer ...

In NK cell-specific SPON2 knockout mouse models ... enabling clinicians to upload standard immunohistochemistry-stained ...

Gilead Sciences' cell therapy Kite Pharma has bulked up its position in natural killer (NK) cell therapies, pledging up to $2.3 billion for a partnership with Shoreline Bioscience focusing on off ...